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Abstract
Remyelination  occurs  in  demyelinated  lesions  in  multiple  sclerosis  (MS)
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and  pharmacological  treatments  that  enhance  this  process  will  critically
impact the long term functional outcome in the disease. Sildenafil, a cyclic
GMP (cGMP)-specific  phosphodiesterase 5 inhibitor  (PDE5-I),  is  an oral
vasodilator  drug  extensively  used  in  humans  for  treatment  of  erectile
dysfunction  and  pulmonary  arterial  hypertension.  PDE5  is  expressed  in
central  nervous  system  (CNS)  neuronal  and  glial  populations  and  in
endothelial  cells  and  numerous  studies  in  rodent  models  of  neurological
disease  have  evidenced  the  neuroprotective  potential  of  PDE5-Is.  Using
myelin  oligodendrocyte  glycoprotein  (MOG)-induced  experimental
autoimmune  encephalomyelitis  (EAE)  as  a  MS  model,  we  previously
showed  that  daily  administration  of  sildenafil  starting  at  peak  disease
rapidly  ameliorates  clinical  symptoms  while  administration  at  symptoms
onset  prevents  disease  progression.  These  beneficial  effects  of  the  drug
involved  down-regulation  of  adaptive  and  innate  immune  responses,
protection  of  axons  and  oligodendrocytes  (OLs)  and  promotion  of
remyelination. In this work we have investigated mechanisms involved in
the  remyelinating  effect  of  sildenafil.  Using  demyelinated  organotypic
cerebellar  slice  cultures  we  demonstrate  that  sildenafil  stimulates
remyelination by direct effects on CNS cells in a nitric oxide (NO)-cGMP-
protein  kinase  G (PKG)-dependent  manner.  We also  show that  sildenafil
treatment  enhances  OL  maturation  and  induces  expression  of  the
promyelinating factor ciliary neurotrophic factor (CNTF) in spinal cord of
EAE mice  and  in  cerebellar  slice  cultures.  Furthermore,  we  demonstrate
that  sildenafil  promotes  a  M2  phenotype  in  bone  marrow  derived
macrophages  (BMDM)  and  increases  myelin  phagocytosis  in  these  cells
and in M2 microglia/macrophages in the spinal cord of EAE mice. Taken
together  these  data  indicate  that  promotion  of  OL maturation  directly  or
through  induction  of  growth  factor  expression,  regulation  of
microglia/macrophage  inflammatory  phenotype  and  clearance  of  myelin
debris may be relevant mechanisms involved in sildenafil enhancement of
remyelination in demyelinated tissue and further support the contention that
this well tolerated drug could be useful for ameliorating MS pathology.
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Introduction
Multiple Sclerosis (MS) is a chronic autoimmune demyelinating disease
characterized by an inflammatory attack on the central nervous system (CNS)
myelin sheaths that causes damage to the underlying axons and leads to
functional impairments and clinical disability (Lassmann 2008; Trapp and
Nave 2008). Neuropathological observations indicate that re-ensheathment of
demyelinated axons, the process termed remyelination, occurs in
demyelinated lesions in MS and may contribute to clinical remittance
(Franklin and Ffrench-Constant 2008). Studies in experimental animal models
of CNS demyelination indicate that remyelination is mediated by
oligodendrocytes (OLs) generated from oligodendrocyte progenitor cells
(OPCs) that proliferate in the germinal zones and are recruited to the lesion
site where they differentiate into mature OLs (Fancy et al. 2011; Maki et al.
2013). Increasing evidence supports the capacity of subsets of activated
resident microglia and infiltrating monocyte-derived macrophages for
promoting remyelination in inflammatory demyelinating disease. In the
experimental autoimmune encephalomyelitis (EAE) model of MS, a shift
toward an anti-inflammatory M2 phenotype is associated with milder disease
symptoms (Mikita et al. 2011) and administration of M2-polarized monocytes
into the cerebrospinal fluid enhances differentiation of OLs (Butovsky et al.
2006). After focal demyelination in the adult mouse brain, the initial
activation of microglia/macrophages to a pro-inflammatory M1 phenotype
appears to drive OPC proliferation but a later switch to a pro-regenerative M2
phenotype is required for progenitors to differentiate into mature OLs and
remyelination to take place (Lloyd and Miron 2016). M2 cells have higher
myelin phagocytic activity than M1 cells (Durafourt et al. 2012). This
property of M2 cells can critically contribute to remyelination since myelin
debris inhibits OPC differentiation (Kotter et al. 2006). Release of trophic
factors and cytokines by M2 microglia/macrophages and reactive astrocytes
will also contribute to create a permissive environment for remyelination (Li
et al. 2016; Rawji et al. 2016). The generation of a nonpermissive
environment or deficits in remyelinating cells may result in the remyelination
failure that occurs as MS progresses. Therapeutic agents that combine anti-
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inflammatory, neuroprotective and remyelinating effects will critically
determine the long-term functional outcome in the disease.
Phosphodiesterase 5 (PDE5), a member of the large family of cyclic
nucleotide hydrolyzing enzymes, is specific for cyclic GMP (cGMP) and its
inhibition will potentiate the actions of this second messenger. Specific
inhibitors of this enzyme (PDE5-Is) such as sildenafil (Viagra®) are oral
vasodilator drugs extensively used in humans for treatment of erectile
dysfunction and pulmonary arterial hypertension, and long-term studies of
daily administration have shown that these drugs are well tolerated and have a
favorable side-effect profile (Frey and Lang 2012; Fusco et al. 2010). In the
CNS, cGMP can be formed by stimulation of nitric oxide-dependent guanylyl
cyclase (NO-GC) that is expressed in neurones, astrocytes, OLs and vascular
endothelial cells (Baltrons and Garcia 2001; Garthwaite et al. 2015;
Garthwaite 1991; Zhang et al. 2003). Astroglial and microglial cells can also
produce cGMP by stimulation of natriuretic peptide receptors (Prado et al.
2010). PDE5 expression has been described in neuronal and glial populations
and cerebrovascular endothelial cells (Bender and Beavo 2004; Prado et al.
2010; Zhang et al. 2003) and PDE5-Is have been shown to exert
neuroprotective actions in rodent models of neurological disease through
different mechanisms. In rats with embolic stroke administration of sildenafil
improves functional recovery in association to enhanced angiogenesis,
neurogenesis, synaptogenesis, axonal remodeling and oligodendrogenesis
(Ding et al. 2008; Menniti et al. 2009; Wang et al. 2005; Zhang et al. 2005;
Zhang et al. 2002; Zhang et al. 2012). PDE5-Is also protect against different
neurotoxins by activating survival pathways (Barros-Minones et al. 2013;
Puerta et al. 2009) and after focal brain lesion by regulating the innate
immune response and promoting antioxidant mechanisms (Pifarre et al. 2010;
Prado et al. 2013). In models of Alzheimer’s disease PDE5-Is ameliorate
synaptic and memory abnormalities by reducing Tau phosphorylation,
amyloid burden and neuroinflammation (Cuadrado-Tejedor et al. 2011; Puzzo
et al. 2009). Reduction of neuroinflammation has been also shown in rats with
hepatic encephalopathy (Hernandez-Rabaza et al. 2015). Interestingly,
sildenafil amelioration of peripheral neuropathy in diabetic mice was reported
to occur concomitantly with increases in myelin sheath thickness and
subcutaneous nerve fibers (Wang et al. 2011). In light of these pleiotropic
effects of PDE5-Is some years ago we hypothesized that treatment with these
drugs could be beneficial in MS. Using EAE induced by immunization with
myelin oligodendrocyte glycoprotein peptide 35–55 (MOG ) as a model35–55
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mimicking many aspects of progressive MS, we initially showed that daily
administration of sildenafil starting at peak disease rapidly ameliorates
clinical symptoms by preventing axonal damage and promoting remyelination
in the spinal cord (SC). These effects were associated with decreased T-cell
infiltration and microglial/macrophage activation and increased presence of T
regulatory cells (Tregs) (Pifarre et al. 2011). The presence of reactive
astrocytes forming scar-like structures around infiltrates was enhanced by
sildenafil suggesting a possible mechanism for restriction of leukocyte spread
into healthy parenchyma. The myelin and axon protective effects of sildenafil
together with reduced inflammatory gene expression have been also observed
in the cuprizone demyelination model (Nunes et al. 2012). In a more recent
work, we showed that administration of the drug at the onset of EAE
symptoms prevents disease progression (Pifarre et al. 2014). Ultrastructural
and immunocytochemical analysis of SCs evidenced that early sildenafil
treatment preserves axons and myelin, protects immature and mature
myelinating OLs and increases the number of axons with remyelinating
appearance. Up-regulation of brain-derived neurotrophic factor (BDNF) in
immune and neural cells suggested its implication in the neuroprotective
effects of the drug. Increased expression of YM-1, a marker of the
macrophage/microglial M2 phenotype was also induced by the treatment.
Furthermore, sildenafil down-regulated the adaptive immune response (Pifarre
et al. 2014). In this work we have further investigated mechanisms involved
in the remyelinating effect of this drug. Using organotypic cerebellar cultures
demyelinated with lysophosphatidylcholine (LPC) we demonstrate that
sildenafil induces remyelination by direct effects on CNS cells in a NO-
cGMP-protein kinase G (PKG) dependent manner. We also show that
sildenafil-treatment enhances OL maturation and ciliary neurotrophic factor
(CNTF) expression in the SC of EAE mice and in demyelinated slice cultures,
regulates the inflammatory phenotype of macrophages and promotes myelin
debris phagocytosis.
Materials and Methods
Animals
All procedures used in studies involving animals were approved by the
Autonomous University of Barcelona Animal and Human Experimentation
Ethics Committee in accordance to the ethical standards of the Federation of
European Laboratory Animal Science Associations (FELASA).
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EAE Induction and Treatments
Two-month old female C57BL/6 mice (Charles River) were housed in the
animal facility of the Universitat Autonoma de Barcelona (UAB) under
constant temperature and provided food and water ad libitum. Chronic EAE
was induced by immunization with MOG  peptide (Scientific Technical
Service, Universitat Pompeu Fabra, Barcelona, Spain) and clinically evaluated
for EAE progression as previously described (Pifarre et al. 2011). As controls
naïve mice were used. After immunization animals were randomly divided in
4 groups before treatment by subcutaneous (s.c) injection with vehicle
(purified water) or sildenafil (10 mg/kg; Sigma-Aldrich) once a day starting at
the onset of clinical symptoms (mean score ≈ 1, loss of tail tonus) or at peak
disease (around 18 days post-immunization; mean score ≈ 2.5, severe hind
limb paraparesis) for 15 days. We previously demonstrated that these
treatment regimens are effective at preventing and ameliorating disease
progression (Pifarre et al. 2014; Pifarre et al. 2011). The sildenafil dose used
is equivalent to 57 mg/day in a 70 kg human, according to Reagan-Shaw et al.
(2008). Mice were sacrificed under pentobarbital anesthesia and SCs were
removed.
LPC-demyelinated Cerebellar Organotypic Cultures
Organotypic cultures were established from cerebellum of 7-day-old C57BL/6
mice (Harlan Inc.) as described by Birgbauer et al. (2004). Mice were
sacrificed by decapitation and cerebella dissected. Sagittal 300 µm cerebellum
slices were obtained with a McIlwain Tissue Chopper. Three or four slices
were seeded per well on culture inserts (Millipore) and incubated at 37 °C and
5% CO  in 50% basal medium Eagle, 25% Hanks’ balanced salt solution,
25% horse serum, 5 mg/ml glucose, 0.25 mM L-glutamine and 25 µg/ml
penicillin/streptomycin (pen/strep) from Sigma-Aldrich. Medium was
changed every 2–3 days. After 7 days in vitro (DIV), slices were
demyelinated by incubation with L-α-lysophosphatidylcholine from egg yolk
(LPC, 0.5 mg/ml; Sigma-Aldrich) for 14 h and afterwards medium was
replaced with LPC-free medium. Twenty-four hours after removing LPC (9
DIV), demyelinated slices were treated with vehicle or cGMP increasing
compounds: sildenafil (1 µM; Sigma-Aldrich) alone or combined with the
NO-GC direct stimulator BAY 41–2272 (3 µM; Tocris), or the glutamate
receptor agonist N-methyl-D-aspartate (NMDA, 30 µM; Sigma-Aldrich).
Treatments were repeated at 12, 14 and 16 DIV and cultured slices were
harvested at 19 DIV. Inhibitors of NO-GC (1H-[1,2,4]oxadiazolo[4,3-
35–55
2
e.Proofing http://eproofing.springer.com/journals/printpage.php?token=W0VTQU...
6 de 43 31/7/17 11:32
a]quinoxalin-1-one, ODQ, 10 µM; Sigma-Aldrich), NO synthase (NOS) (L-
nitroarginine, L-NNA, 100 µM; Sigma-Aldrich) or PKG (Rp-8-(para-
chlorophenylthio) guanosine-3′,5′-cyclic monophosphorothioate,
Rp-8pCPTcGMP, 10 µM; Biolog) were added 24 h before the initiation of
treatments (8 DIV) and combined with treatments thereafter. Concentrations
of drugs used have been previous demonstrated by us and others to be
effective in CNS cell cultures and slices (Boran and Garcia 2007; Ferrero and
Torres 2001; Garthwaite et al. 2015; Poppe et al. 2008; Stasch et al. 2001).
Isolation, Culture and Polarization of Mouse Bone Marrow-
derived Macrophages (BMDM)
BMDM were generated from C57BL/6 mice (Harlan Inc.) as previously
described (Classen et al. 2009). Briefly, bone marrow was extracted and
plated in 150 mm diameter culture dishes and incubated in Dulbecco’s
Modified Eagle’s Medium (DMEM; Sigma-Aldrich) supplemented with
10 ng/ml recombinant mouse macrophage colony stimulating factor (M-CSF;
Immunotools), 20% fetal bovine serum (FBS; Gibco) and 1% pen/strep for
7 days. A second boost of 5 ng/ml M-CSF was given on the 4th day. After,
cells were re-seeded at the appropriate density and incubated for 18 h in
DMEM-10% FBS-1% pen/strep at 37 °C in 5% CO . Polarization to M1
phenotype was induced by incubation with 10 ng/ml lipopolysaccharide from
Salmonella typhimurium (LPS; Sigma-Aldrich) plus 20 ng/ml interferon
gamma (IFNγ; Millipore), and to M2 phenotype with 20 ng/ml interleukin 4
(IL-4; Immunotools). Cells were treated with sildenafil (1–100 µM), or cGMP
analogues 8-Br-cGMP (500 µM; Tocris) or 8-(4-chlorophenylthio)-cGMP
(8pCPTcGMP, 50 µM; Sigma-Aldrich) alone or with the phenotype
polarization stimuli. PKG inhibitors Rp-8pCPTcGMP (1 µM; Biolog) or
Rp-8-Br-β-phenyl-1,N2-ethenoguanosine 3′,5′-cyclic monophosphorothioate
sodium salt (Rp-8Br-PET-cGMP; 0,5 µM; Sigma) were added 30 min before.
Cells were incubated for 24 h for morphology examination, arginase activity,
nitrite measurement and phagocytosis determination, 18 h for Luminex
cytokine assay and 48 h for flow cytometry.
Histological Methods
Cervical-thoracic SCs and cultured cerebellar slices were fixed in 4%
paraformadehyde (PFA). SCs sections were cut into coronal or longitudinal
16 µm-thick slices (Microtome Cryostat Thermoshandon). For intracellular
staining tissue was permeabilized with Triton X-100 (Sigma-Aldrich) 0.1%
2
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for SCs and 0.3% for cultured cerebellar slices. After blocking with
phosphate-buffered saline (PBS)-10% normal goat serum (NGS), samples
were incubated with the appropriate dilution of the following primary
antibodies: rat anti-myelin basic protein (MBP, Abcam; 1:200) and rabbit
anti-contactin-associated protein (Caspr, Abcam; 1:1000), mouse anti-NF-200
(Sigma-Aldrich; 1:400), rabbit anti-Olig2 (Millipore; 1:500), mouse anti-
NOS-2 (BD; 1:100), goat anti-CNTF (RD Systems; 1:75), rabbit anti-glial
fibrillary acidic protein (GFAP, Dako; 1:900), mouse anti-Nkx2.2 (DSHB
75.5A5, developed by Jessell, T.M. and Brenner-Morton, S.; 1:200), mouse
anti-CD68 (Serotec; 1:100) and rabbit anti-YM-1 (StemCell Tech; 1:75). For
colorimetric assays biotin-conjugated secondary antibodies that were detected
by streptavidin/horseradish peroxidase and the peroxidase substrate DAB kit
were used (Vector). For fluorescence staining Alexa-488 and 568-conjugated
secondary antibodies (Invitrogen Molecular Probes) were used. Nuclei were
stained with DAPI (0.25 µg/ml). Control sections were incubated in the
absence of primary antibodies. Oil-Red-O (ORO) staining was performed in
SC longitudinal sections as previously described with slight modifications
(Koopman et al. 2001). Briefly, a solution of 0.5% w/v ORO (Sigma-Aldrich)
in 60% triethyl-phosphate was diluted to 60% in deionized water. Sections
were incubated at room temperature in ORO solution, washed twice and
embedded in 10% glycerol containing DAPI.
Bright field images were acquired using an Eclipse 90i microscope with
Nikon Digital camera DXM 1200F and Nikon Act-1 software. Confocal
images were acquired using a microscope Zeiss LSM 700 with ZEN 2010
software. Colocalization of MBP/NF200 and Caspr/NF200 were obtained by
Fiji ImageJ software. 3D reconstruction of YM1-ORO staining was performed
with Imaris software. Quantification of CNTF, MBP and ORO staining
intensity was performed with Scion Image (NIH) software in 4–8 areas
(1 mm ) randomly chosen along the length of 2–3 longitudinal SC sections
separated at least 300 µm. Quantification of single (Nkx2.2) and double
(MBP-Olig2) stained cells was performed manually using Fiji ImageJ
software in 2–3 SC sections separated at least 300 µm or in 5–6 areas of
organotypic cultures. All images were analyzed by two independent
investigators blinded to treatment and clinical score.
Western Blot Analysis
Four cerebellar slices per condition (in triplicates) were homogenized using
RIPA buffer (Merk-Millipore) with anti-phosphatase (Sigma-Aldrich) and
2
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anti-protease cocktails (Roche). Thirty µg of protein were subjected to 4–12%
NuPAGE Novex Bis-Tris Midi-Gels (Thermo Fisher Scientific). Transference
was performed with iBlot system (Invitrogen) into PVDF membranes. For
blot staining, membranes were blocked at 4 °C overnight in 5% w/v non-fat
dry milk in PBS and were further incubated with the appropriate dilution of
primary antibodies: rat anti-MBP (1:200) and mouse anti-2′,3′-cyclic-
nucleotide 3′-phosphodiesterase (CNPase; 1:200) from Abcam and mouse
anti-glyceraldehyde-3-phosphate dehydrogenase (GAPDH; 1:20,000) from
Ambion. Horseradish peroxidase (HRP) coupled anti-rat (Thermo Fisher) and
anti-mouse (Sigma-Aldrich) secondary antibodies were used and staining was
revealed using Luminata Forte Western HRP substrate (Millipore) in a
molecular imager ® VersaDoc ™ MP Imaging System (Bio-Rad). The
intensity was quantified in 2–3 independent experiments using Quantity One
software (BioRad) and expressed relative to LPC-treated cultures. Values
were normalized to GAPDH levels.
mRNA Extraction and qPCR
mRNA extraction was performed in cultured cerebellar slices (4 slices per
condition) using Maxwell® RSC simplyRNA Tissue Kit (Promega) following
user’s manual instructions. Reverse transcription was carried out by iScript
(BioRad) following the supplier’s instructions. qPCR was performed by iTaq
Super Mix (BioRad). To determine changes in CNTF gene expression the
sense TCGTTCAGACCTGACTGCTC and anti-sense
ACTCCAGCGATCAGTGCTTG primers (NM_170786.2) and Bio-Rad CFX
Touch™ Real-Time PCR Detection System were used. Further analysis was
performed by Bio-Rad CFX Manager™ 3.1 Software. Hypoxanthine-guanine
phosphoribosyltransferase (HPRT) was used as reference gene, sense
GATTAGCGATGATGAACCAGGTT and anti-sense
CCTCCCATCTCCTTCATGACA (NM_013556.2). Relative gene expression
was assessed using the ∆∆Cq Method (Livak and Schmittgen 2001).
Determination of Arginase Activity and Nitrites in BMDM
Cultures
BMDM were seeded in 96-well plates at a density of 2 × 10  cells/ml.
Arginase activity was determined as previously described (Classen et al.
2009) with slight modifications. Briefly, cells were lysed and arginine
hydrolysis was performed by incubating the lysate with L-arginine at 37 °C
for 60 min. Afterwards lysates were combined with 6%
5
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α-isonitropropiophenone and the concentration of urea produced was
determined by reading the absorbance at 540 nm in a multilabel plate reader
VICTOR 3 (PerkinElmer). One unit of enzyme activity was defined as the
amount of enzyme that catalyzes the formation of 1 µmol urea per minute.
Data was expressed as units of arginase activity per 1 × 10  cells. Results are
presented as percentage of activity respect to untreated controls. Nitrite
concentration in the media was measured with the Greiss reagent.
M1/M2 Phenotype Analysis of BMDM by Flow Cytometry
After stimulation, BMDM were washed and harvested in Ca /Mg -free PBS
by softly scraping. Cells were centrifuged and resuspended in the same buffer
at a concentration of 1 × 10  cells/ml. For M2 cell staining the cell membrane
marker CD206 was used. After blocking with TruStain FcX anti–mouse
CD16/32 (Biolegend; 1:100), cells were stained with Alexa Fluor 488 coupled
anti-CD206 antibody (BiolegendM; 1:100), washed and fixed in 1% PFA. For
M1 cell staining the intracellular marker NOS-2 was used. Cells were fixed in
1% PFA, blocked and permeabilized with PBS-0.5% Tween-20 and 10%
NGS. Cells were resuspended in primary anti-NOS-2 antibody (BD; 1:100)
and incubated for 2 h at RT. The appropriate Alexa-coupled secondary
antibody was used. Cells incubated in the absence of primary antibody were
used as controls. Flow cytometry was performed using a FACScanto flow
cytometer (BD Biosciences; 10,000 events per sample). Cell population was
first gated by cell size (forward scatter, FSC) and complexity (side scatter,
SCC) and were afterwards excited with the 488 nm laser and fluorescence
emission measured with 530 nm filter detector. Positive gates were set with
negative controls. Data analysis was performed with the BD FACSDiva
Software.
Measurement of TNFα and IL-1β Release
BMDM seeded at 1 × 10  cells/ml in six-well plates were used. TNFα and
IL-1β cytokine levels were measured in supernatants of treated cells using
Luminex technology. The MILLIPLEX® MAP Mouse Cytokine/Chemokine
Magnetic 96-well plate Bead Panel Millipore (MCYTOMAG-70 K) assay was
used following the manufacturer’s instructions. Results were analyzed with
the Milliplex Analyte program version 5.1.0.0.
Myelin Phagocytosis by BMDM
Myelin was isolated from SC and cerebella of naïve mice as previously
6
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described (Larocca and Norton 2007). A concentration of 1 mg/ml of isolated
myelin was labelled with 12.5 µg/ml of 1,1″-diotadecyl-3,3,3′,3′-tetramethyl-
lindocarbocyanide perchlorate (DiI, Sigma-Aldrich) for 30 min at 37 °C and
the phagocytosis assay was performed as previous described (Hendriks et al.
2008). Briefly, BMDM were plated in 24-well plates at a density of 5 × 10
cells/ml un-polarized and M2- polarized cells were treated with sildenafil
30–100 µM or the cGMP analogue 8Br-cGMP (500 µM) for 24 h. Afterwards
cells were incubated with 25 µg/ml Dil-labelled myelin for 90 min at 37 °C.
Afterwards cells were detached and fluorescence was determined using a BD
FACScalibur cytometer. Mean intensity times number of Dil-positive cells
was used to quantify myelin phagocytosis.
Statistical Analysis
Differences were analyzed by one- or two-way ANOVA followed by the
appropriate post-hoc test as indicated using GraphPad Prism v5 software.
Student’s t-test was used for two group comparisons. Results shown are
means ± SEM of the indicated number of animals (EAE) or independent
cultures (organotypic and BMDM) or means ± SD of different measures in a
representative experiment. Differences were considered significant at P values
lower than 0.05 (p < 0.05).
Results
Sildenafil Promotes Remyelination in LPC-demyelinated
Mouse Cerebellar Organotypic Cultures
To investigate if the remyelinating effect of sildenafil we previously observed
in EAE mice involved effects on CNS cells or also required peripheral
immunoregulatory actions, we used the in vitro model of mouse cerebellar
organotypic cultures (ORG) demyelinated with LPC. Cultures were
established from cerebella of 7-day-old C57BL/6 mice as described in
Methods. After 7 DIV, cerebellar slices were exposed to LPC (0.5 mg/ml) for
14 h, a treatment that causes a striking demyelination without neuronal death
(Birgbauer et al. 2004). Twenty-four hours after removing LPC, cultures were
treated with sildenafil (1 µM every 2–3 days) alone, or in combination with
the NO-GC allosteric enhancer BAY 41–2272 (BAY41; 3 µM), or the
glutamate receptor agonist NMDA (30 µM) that stimulates NO formation by
the constitutive Ca -dependent NO synthase in granule cells and this NO can
subsequently target NO-GC in astrocytes, oligodendrocytes and endothelial
cells (Garthwaite 1991). At 19 DIV, cerebellar slices were harvested, double
5
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immunofluorescence-stained for axon neurofilament NF200 and for the major
myelin protein MBP and analyzed by confocal microscopy. As shown in Fig.
1a, exposure to LPC produced a great reduction in MBP staining around
axons and cell bodies compared to control slices. Treatment of LPC-
demyelinated slices with cGMP-increasing compounds notably enhanced
MBP staining (50–70%). Quantification of the remyelination index (RI; area
stained for MBP relative to area stained for NF200) showed that
remyelination induced by sildenafil alone was not significantly different from
that attained in combination with BAY41 (BAY41 + Sil) or NMDA
(NMDA + Sil), although the combination with the NO-GC activator appeared
to be somewhat more effective (Fig. 1b). Remyelination attained with BAY41
alone was 40% lower than that induced by BAY41 + Sil (not shown),
indicating that PDE5 inhibition by sildenafil is sufficient to enhance cGMP
accumulation and suggesting that an endogenous source of NO is responsible
for NO-GC stimulation. In agreement with the immunostaining data, analysis
by WB of levels of MBP and of CNPase showed a significant increase of both
myelin proteins in the demyelinated slices after treatment with BAY41 + Sil
(Fig. 1c,d). The presence of Caspr clusters in the paranodes delimiting myelin
sheaths correlates with a proper remyelination of axons (Arancibia-Carcamo
and Attwell 2014). To investigate the remyelination status of the cerebellar
cultures, double immunostaining for Caspr and NF200 was performed. As
expected, Caspr clusters associated with axons were drastically reduced in
LPC-demyelinated cultures (Fig. 1e). Treatment with sildenafil or
BAY41 + Sil largely restored Caspr staining levels and distribution (Fig. 1e,f).
Fig. 1
Sildenafil promotes remyelination in LPC-demyelinated cerebellar organotypic
cultures.  (a)  Representative  images  of  MBP  (green)  and  NF200  (red)
immunostaining in control and LPC (0.5 mg/ml)-demyelinated cerebellar slices
treated or not for 10 days with sildenafil (1 µM) alone or in combination with
the NO-GC activator BAY41–2272 (3 µM) or the glutamate receptor agonist
NMDA (30 µM); scale bar = 20 µm; (b)  Quantification of MBP and NF200
staining overlap (RI, remyelination index) reveals a drastic reduction in LPC-
demyelinated cultures and recovery in cultures treated with sildenafil alone or
in combination with cGMP synthesis stimuli. Values are means ± SEM of three
independent  experiments.  One-way  ANOVA revealed  statistically  significant
differences  among  treatments  (p  <  0.001).  Bonferroni’s  post-hoc  analysis
indicated significant differences between control and LPC-demyelinated slices
( p < 0.01, p < 0.001) and between LPC-demyelinated slices treated or not
with  cGMP-increasing  compounds  (**p  <  0.01,  ***p  <  0.001);  (c)  and  (d)
## ###
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Representative  WBs  for  MBP  and  CNPase  in  triplicate  samples  of  LPC-
demyelinated slices  treated with vehicle  or BAY41 + Sil  in  one experiment.
Protein  levels  were  normalized  to  GAPDH.  Results  from  three  independent
experiments  are  presented  in  the  graph  relative  to  levels  in  vehicle-treated
samples and are means ±SEM of three independent experiments for MBP and
two  for  CNPase.  The  treatment  significantly  increased  myelin  proteins
(Student’s t-test, **p < 0.01); (e) Double immunostaining of paranodal protein
Caspr (green) and NF200 (red) in LPC-demyelinated slices treated or not with
sildenafil  or  BAY41 + Sil.  Representative  images  of  Caspr  mascara  (white);
small  panels  show  Caspr  clusters  over  axons.  (f)  Quantification  of  area
immunostained for  Caspr relative to the area stained for  NF-200.  Values are
means ± SD (5–6 images per condition) in a representative experiment that was
replicated  with  similar  results.  One-way  ANOVA  revealed  significant
differences  among  treatments  (p  <  0.01).  Bonferroni’s  post-hoc  analysis
revealed  significant  differences  between  control  and  vehicle-treated  LPC-
demyelinated  slices  ( p  <  0.05)  and  between  vehicle-  and  sildenafil-  or
BAY41 + Sil-treated slices (*p < 0.05)
#
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The NO-cGMP-PKG Pathway is Involved in the
Remyelinating Effect of Sildenafil in LPC-demyelinated
Cerebellar Cultures
As mentioned above, the observation that treatment of demyelinated
cerebellar slices with sildenafil alone produced a similar remyelinating effect
than its combination with BAY41 or NMDA, stimuli that increase cGMP
production via NO-GC, suggested that endogenous activation of this enzyme
was involved in the sildenafil effect. In agreement with this assumption
sildenafil-induced remyelination was prevented by the NO-GC inhibitor ODQ
(10 µM; Fig. 2a), as well as by the NOS inhibitor L-NNA (100 µM; Fig. 2b).
The remyelinating effect of sildenafil also required PKG activity since it was
prevented by the specific inhibitor Rp-8pCPTcGMP (10 µM) (Fig. 2c).
Treatment with ODQ, but not L-NNA or Rp-8pCPTcGMP, significantly
decreased (30%) the amount of myelin associated with axons in control
cultures which may be due to some toxic effect in the immature cerebellar
slices under prolonged exposure, as reported to occur in cultured rat brain
OLs (Garthwaite et al. 2015) and other cells types (Haramis et al. 2008). A
potential source of NO in LPC-demyelinated slices is the induction of NOS-2
in reactive glial cells, predominantly in microglia (Miron et al. 2010).
Immunofluorescence staining for NOS-2 in the cerebellar cultures showed
that while only a few cells stained for NOS-2 in control cultures, numerous
cells showing a rounded morphology more typical of activated microglia than
of activated astrocytes were NOS-2 positive in cultures exposed for 24 h to
LPC, or to LPS (1 µg/ml) used as a positive control (Fig. 2d).
Fig. 2
The remyelinating effect of sildenafil in LPC-demyelinated cerebellar cultures
is  prevented  by  inhibitors  of  NO-GC,  NOS-2  and  PKG  activities.  The
remyelination  index  was  quantified  in  control  or  LPC-demyelinated  slices
treated or not with sildenafil (1 µM) in the presence of: (a) the NO-GC inhibitor
ODQ (10 µM; n = 2); (b) the NOS-2 inhibitor L-NNA (100 µM; n = 3); (c) the
PKG inhibitor Rp-8pCPT-cGMP (10 µM; n = 3). Results are means ± SEM of
2–3 independent experiments. Two-way ANOVA showed significant differences
between  treatments  in  all  cases  (a,  p  <  0.001;  b,  p  <  0.05;  c,  p  <  0.01).
Bonferroni’s post-hoc analysis revealed significant effects of ODQ in vehicle
(*p < 0.05) and sildenafil-treated slices (***p < 0.001) and of Rp-8pCPTcGMP
in  sildenafil-treated  slices  (*p  <  0.05);  (d)  NOS-2  induction  shown  by
immunostaining (green) in cerebellar slices 24 h after LPC or LPS treatment.
DAPI-stained nuclei (blue). Scale bar = 20 µm
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Sildenafil Promotes OL Maturation in the SCs of EAE Mice
and in LPC-demyelinated Cerebellar Cultures
Effects of sildenafil treatment on OL maturation were examined in the SCs of
EAE animals treated for 15 days at peak disease by immunostaining for
Nkx2.2 and Olig2, transcription factors involved in OL linage specification
and differentiation (Fancy et al. 2004; Takebayashi et al. 2000; Zhu et al.
2014), and for the mature OL marker MBP. As shown in Fig. 3a, staining
intensity of Nkx2.2+ cells (green) in thoracic longitudinal sections of EAE
mice SCs was increased after sildenafil treatment. Quantification of bright
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Nkx2.2+ cells (high expression) confirmed a significant increase respect to
vehicle-treated animals (Fig. 3a). In agreement with our previous results using
Luxol Fast Blue staining (Pifarre et al. 2011), total MBP immunostaining in
SC longitudinal sections showed a 3-fold increase in sildenafil-treated
animals (Fig. 3b, upper graph). A tendency to increase was also observed in
the total number of MBP+ cells/mm  (Fig. 3b, lower graph). Double-
immunostaining for MBP (green) and Olig2 (red) showed that both
MBP+/Olig2+ cells (yellow arrows; left graph) and MBP+/Olig2- cells (white
arrows; middle graph) increased respect to the time of initiation of treatment
(peak) in vehicle-treated as well as sildenafil-treated animals (Fig. 3c).
Further analysis of the percentage of MBP+/Olig2- cells (mature OLs) respect
to total MBP+ cells showed a significant increase in dorsal and ventral
thoracic SC sections of sildenafil-treated animals compared to vehicle-treated
controls (Fig. 3c, right graph). A significant increase in MBP+/Olig2−
cells/mm cells was also observed in sildenafil- and BAY41 + Sil-treated
LPC-demyelinated cerebellar slices (Fig. 3d, white arrows). Taken together
these results support the role of cGMP in OL maturation, in agreement with
recent observations in brain of ischemic mice (Zhang et al. 2012) and in OL
cultures (Garthwaite et al. 2015), and implicate this mechanism in the
remyelinating effect of sildenafil.
Fig. 3
Sildenafil  treatment promotes OL maturation in the SC of EAE mice and in
LPC-demyelinated  cerebellar  cultures.  (a)  Representative  images  of
immunostaining  for  Nkx2.2  (left)  and  quantification  of  bright  Nkx2.2  cells
(high  expression,  white  arrows)  (right)  showing  a  significant  increase  after
sildenafil treatment. Values are means ± SEM (n = 3–6 mice/group; *p < 0.05,
Student’s  t-test).  (b)  Total  MBP  immunostaining  in  cervical-thoracic
longitudinal  SC  sections  of  EAE  mice  treated  with  sildenafil  for  15  days
starting at  peak disease  showed a  significant  increase  (upper  graph)  and  the
number of MBP+ cells showed a tendency to increase (lower graph). Values are
means ± SEM (n = 3–6 mice/group; **p < 0.01, Student’s t-test). (c)  Double
immunostaining for MBP (green) and Olig2 (red) in longitudinal SC sections of
EAE mice showed that both MBP+/Olig2+ cells (yellow arrows, left graph) and
MBP+/Olig2- cells (white arrows, middle graph) increase respect to the time of
initiation  of  treatment  (peak)  in  both  vehicle-  and  sildenafil-treated  animals.
Further  quantification  of  MPB+/Olig2-  cells  relative  to  total  MBP+ cells  in
dorsal and ventral areas showed a significant increase after sildenafil treatment
(right  graph)  analyzed  by  two-way  ANOVA  (p  <  0.001)  followed  by
Bonferroni’s post-hoc test (*p  < 0.05, **p  < 0.01). Values are means ± SEM
2
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(n = 3–5 mice/group). (d) Representative images of double immunostaining for
MBP  (green)  and  Olig2  (red)  in  control  and  LPC-demyelinated  cerebellar
cultures treated or not with sildenafil (1 µM) or BAY41 (3 µM) + Silsildenafil
(1  µM);  MPB+/Olig2+ cells  (yellow arrows)  and  MPB+/Olig2-  cells  (white
arrows);  Quantification  of  total  MBP+/Olig2-  cells/mm  (right)  showed  a
significant  increase  in  LPC-demyelinated  slices  after  cGMP  increasing
treatments using a one-way ANOVA (p < 0.01) followed by Bonferroni’s post-
hoc test (**p < 0.01). Values are means ± SEM of two independent experiments
(n = 2). Scale bars = 20 µm
Sildenafil Increases CNTF Expression in SC of EAE Mice
and in LPC-demyelinated Cerebellar Cultures
CNTF has a recognized influence on OL differentation (Stankoff et al. 2002).
Recent in vitro studies have demonstrated that the NO-cGMP-PKG pathway
2
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up-regulates CNTF expression in astrocytes and that astrocyte-derived CNTF
enhances OL differentiation (Paintlia et al. 2013). Using double
immunostaining for CNTF and the astrocyte protein GFAP we have observed
CNTF expression in resting astrocytes in the SC of naïve animals, as well as
in reactive astrocytes in the SC of EAE animals (Fig. 4a, arrowhead).
Quantification of CNTF staining intensity in longitudinal slices of SC showed
that treatment with sildenafil for 15 days (15 dot) at peak EAE notably
enhanced CNTF immunostaining in cells with morphological appearance of
astrocytes (Fig. 4b). A significant increase in CNTF mRNA expression was
also observed in LPC-demyelinated cerebellar slices 24 h after the first
treatment (T1, 9DIV) with BAY41 + Sil but not after the third treatment (T3,
14 DIV) (Fig. 4c). These results suggest that induction and release of CNTF
may be a factor contributing to the effect of cGMP-increasing compounds on
OL maturation and remyelination.
Fig. 4
Sildenafil treatment increases CNTF expression in the SC of EAE mice and in
LPC-demyelinated cerebellar  cultures.  (a)  Double  immunostaining  for  GFAP
(red) and CNTF (green) in coronal SC cervical sections showing colocalization
(arrowheads) in resting astrocytes in naïve animals and in reactive astrocytes
surrounding a leukocyte infiltrate (asterisk) in EAE animals. Scale bar = 50 µm;
(b) Representative images of CNTF immunostaining in longitudinal SC cervical
sections of EAE animals treated with vehicle or sildenafil for 15 days (15 dot)
starting at peak disease showing increased staining in cells with morphological
appearance  of  astrocytes  (scale  bar  =  20  µm).  Quantification  of  staining
intensity values are means ± SEM (n  = 5 mice per group, p  = 0.07, Student
t-Test);  (c)  CNTF  mRNA  levels  assessed  by  qPCR  in  LPC-demyelinated
cerebellar  cultures  24  h  after  the  first  (T1,  9  DIV)  and  third  (T3,  14  DIV)
treatments with BAY41 (3 µM) + Silsildenafil  (1 µM), showing a significant
increase in CNTF expression after the first treatment. Values are means ± SEM
fold-change  in  three  independent  experiments.  Two-way  ANOVA  showed
significant  differences  respect  to  treatment  (p  <  0.05)  and  treatment  time
(p  <  0.001).  Bonferroni’s  post-hoc  analysis  revealed  significant  differences
between LPC-demyelinated cultures treated or not with BAY41 + sSil for 24 h
after removing LPC (**p < 0.01)
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Treatments that Increase cGMP Induce a M2-Phenotype in
BMDM
Our previous studies in EAE mice have shown that after sildenafil treatment
expression of the classical microglia/macrophage activation marker Iba-1 in
the SC was decreased while that of the alternative activation marker YM-1
was increased (Pifarre et al. 2014; Pifarre et al. 2011). In order to directly
examine the potential of cGMP-increasing compounds to modulate the
inflammatory phenotype in macrophages, we used mice BMDM in primary
culture. These cells are readily polarized to a M1 phenotype by incubation
with LPS (10 ng/ml) + IFNγ (20 ng/ml) and to a M2 phenotype by incubation
with IL-4 (20 ng/ml) (Classen et al. 2009). These conditions were used as
controls of phenotypic changes. As shown in Fig. 5a, treatment of BMDM
with sildenafil (30–100 µM, 24 h) induced a change in cell morphology from
a round/amoeboid shape to an elongated shape (left panels) similar to that
induced by treatment with IL-4 (upper right panel). Moreover, the
combination of sildenafil (30 µM) with IL-4 (20 ng/ml) appeared to induced
further process elongation (middle right panels). The morphological change
induced by sildenafil required PKG activity since it was prevented by the
PKG inhibitor Rp-8pCPTcGMP (1 µM) (Fig. 5a, lower right panels). We
further investigated if sildenafil could promote a shift from a M1 to a M2
phenotype in BMDM by analyzing nitrite concentration in the media as an
index of NOS-2 induction (M1 effect), and arginase activity as an index of
Arg1 gene expression (M2 effect), in cultures treated with sildenafil alone
(1–100 µM) or in combination (added 60 min before) with the inflammatory
stimuli for 24 h. As expected, LPS + IFNγ induced a large increase in nitrite
concentration in the media while IL-4 or sildenafil had no effect. Sildenafil
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did no significantly affect LPS + IFNγ-induced nitrite accumulation (Fig. 5b,
upper graph). In contrast, arginase activity showed a tendency to increase at
high sildenafil concentrations (30–100 µM) in control and LPS + IFNγ-treated
cells and a significant 2–3-fold increase in IL-4-treated cells (Fig. 5b, lower
left graph). This later effect was prevented by preincubation with the PKG
inhibitor Rp-8Br-PET-cGMP (0,5 µM) (Fig. 5b, lower right graph). These
results suggested that sildenafil was promoting a M2 phenotype but not
properly inducing a shift from a M1 to a M2 phenotype. In order to confirm
the induction of these phenotype changes by cGMP we analyzed by flow
cytometry the percentage of cells expressing NOS-2 or the M2 marker CD206
in BMDM treated with the cGMP analogue 8pCPTcGMP (50 µM) alone, or in
combination with LPS + IFNγ or IL-4. As shown in Fig. 5c (left), more than
80% percent of the cells expressed NOS-2 in LPS + IFNγ-treated BMDM,
whereas the number of cells expressing this M1 marker was minimal in
control cells or in cells treated with IL-4. In agreement with the nitrite data,
8pCPTcGMP did not affect the percentage of cells expressing NOS-2 in
LPS + IFNγ-treated BMDM (Fig. 5c, left graph). As expected, the number of
cells expressing the M2 marker CD206 was increased by treatment with IL-4
but not with LPS + IFNγ (Fig. 5c, right). The cGMP analogue alone had a
small effect to the limit of significance in control cells and notably increased
the effect of IL-4 (Fig. 5c, right graph). We further analyzed the levels of pro-
inflammatory cytokines (IL-1β and TNFα) in the media of BMDM 18 h after
treatment with the same stimuli. As expected, an increase in both pro-
inflammatory cytokines was detected in the media of LPS + IFNγ-treated- but
not IL-4-treated BMDM (Fig. 5d). The cGMP analogue significantly reduced
the release of both cytokines induced by the pro-inflammatory stimuli
indicating that it has an anti-inflammatory effect. Surprisingly, while the
cGMP analogue alone did not significantly increase basal levels of IL-1β, it
did significantly induce the release of TNFα in control cells as well as in cells
treated with IL-4 (Fig. 5d).
Fig. 5
Sildenafil alters the inflammatory phenotype of mouse BMDM. (a, left panels)
Treatment  of  C57BL/6  mice  BMDM with  sildenafil  (30–100  µM)  for  24  h
induced process elongation (arrow) and lamellipodia formation (arrowheads).
This morphological change was similar to that produced by IL-4 (20 ng/ml), a
M2 phenotype inducer (upper right panels). Combination of sildenafil with IL-4
appeared  to  induce  further  process  elongation  (middle  right  panels).  The
specific  protein  kinase  G  (PKG)  inhibitor  Rp-8pCPTcGMP  (1  µM;  added
30 min before) prevented the effect of sildenafil (lower right panels); Scale bar:
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100  µm  left  panels  and  50  µm  right  panels;  (bb,  upper  graph)  Nitrite
accumulation  in  the  media  was  induced  by  the  M1  phenotype  stimuli  LPS
(10  ng/ml)  +  INFγ  (20  ng/ml)  but  was  not  affected  by  IL-4  (20  ng/ml)  or
sildenafil (1–100 µM); (b, lower graph) Arginase activity showed a tendency to
increase at high sildenafil concentrations in control cells and LPS + INF-treated
cells and a significant increase at 30–100 µM in IL-4-treated cells. Results are
means  ± SEM,  n  =  3  (two-way  ANOVA  p  <  0.001;  Bonferroni’s  post-hoc
analysis ***p < 0.001). Treatment with the PKG inhibitor Rp-8Br-PET-cGMP
(0,5  µM;  added  30  min  before)  prevented  the  increase  in  arginase  activity
induced  by  sildenafil  in  IL-4-treated  BMDM  (lower  right).  Values  are
means ± SD (triplicates per condition) in a representative experiment that was
replicated  with  similar  results.  One-way  ANOVA  (p  <  0.001)  followed  by
Bonferroni’s  post-hoc  analysis  showed  significant  differences  between  IL-4
alone and combined with sildenafil (***p < 0.001) and between sildenafil alone
and combined with  the  PKG inhibitor  ( p  <  0.001).  (c)  FACS analysis  of
BMDM  positive  for  the  M1  phenotype  marker  NOS-2  (left)  or  the  M2
phenotype  marker  CD206  (right)  in  untreated  (control)  or  treated  with
LPS  +  IFNγ  or  IL-4  alone,  or  in  combination  with  the  cGMP  analogue
8pCPTcGMP (50 µM, added 30 min before); (lower left graph) the significant
increase in NOS-2 positive cells induced by LPS + IFNγ (p < 0.001, two-way
ANOVA) was not affected by 8pCPTcGMP; (lower right graph) CD206 positive
cells  were  significantly  increased  by  IL-4  (two-way  ANOVA  p  <  0.001).
8pCPTcGMP alone had a small effect to the limit of significance (p  = 0.056)
and  notably  potentiated  the  effect  of  IL-4  (Bonferroni’s  post-hoc  analysis,
***p  < 0.001).  Values are means  ± SEM of  two (NOS-2)  or  three (CD206)
independent  experiments;  (d)  TNFα  and  IL-1β  measured  by  Luminex
technology in the media of BMDM treated for 18 h with LPS + IFNγ, IL-4 or
8pCPTcGMP  alone  or  in  combination.  Cytokine  release  was  significantly
induced by LPS + IFNγ (two-way ANOVA; TNFα, p < 0.001, IL-1 β, p < 0.01).
The cGMP analogue significantly increased TNF release in control and IL-4-
treated  cells  and  decreased  the  induction  by  LPS +  IFNγ  of  both  cytokines
(Bonferroni’s  post-hoc  analysis  *p  <  0.05;  **p  <  0.01)  Results  are
means ± SEM, n = 2
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Sildenafil Increases Myelin Phagocytosis in
Microglia/Macrophages in SC of EAE Animals and in
BMDM
It has been reported that myelin clearance correlates with increased
differentiation of OPCs and remyelination (Kotter et al. 2006) and that M2
cells have higher myelin phagocytic activity than M1 cells (Durafourt et al.
2012). To investigate if sildenafil treatment was affecting myelin debris
phagocytosis we performed ORO staining of myelin in longitudinal SC
sections of EAE mice treated from disease onset when immune cell
infiltration and inflammation are maximal. Figure 6a-d show representative
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images of ORO staining in infiltrates (cell nuclei stained with DAPI) in
animals treated with vehicle (a,c) or sildenafil (b,d) for 7 (a,b) or 15 days
(c,d). Quantification revealed that sildenafil significantly enhances ORO
staining in an area of similar density of infiltration. A significant increase in
vesicular ORO-staining was shown in mice treated with sildenafil for 15 days,
but not for 7 days, respect to vehicle-treated controls (Fig. 6e). Double
staining for ORO and the macrophage/microglial activation marker CD68 or
the M2-phenotype marker YM-1, followed by confocal analysis, showed that
ORO staining was low in CD68+ cells present in the SC of vehicle- and
sildenafil-treated EAE mice (Fig. 6f, upper images). In contrast,
YM-1 + −cells that were only present in sildenafil-treated animals contained
numerous ORO stained vesicles (Fig. 6f, lower images, and Fig. 6g). To
examine if sildenafil has a direct effect on the myelin phagocytic capacity of
macrophages, an in vitro myelin phagocytosis assay was performed in mouse
BMDM. Cells were treated with IL-4 (20 ng/ml), sildenafil (30–100 µM) or
the cGMP analogue 8Br-cGMP (500 µM) alone or in combination. After 24 h,
cells were incubated with Dil-labelled myelin (25 µg/ml, 90 min) and myelin
uptake was analyzed by flow cytometry. Sildenafil and the cGMP analogue
significantly increased myelin phagocytosis both in vehicle- and IL-4-treated
cells (Fig. 6h,i). The effect of cGMP-increasing stimuli was of higher
magnitude than that of IL-4 and when added in combination with the cytokine
their effects were less than additive suggesting that they may share
mechanisms.
Fig. 6
Sildenafil  treatment enhances myelin  phagocytosis  by microglia/macrophages
in  the  SC of  EAE animals  and  by  BMDM in  culture.  (a–d)  Representative
images  of  ORO  staining  in  infiltrates  (cell  nuclei  stained  with  DAPI)  of
different size in animals treated with vehicle (a,c) or sildenafil (10 mg/kg) (b,
d) for 7 (a,b) or 15 (c,d) days (dot) starting at disease onset. Scale bar = 20 µm;
(e)  Quantification of ORO staining revealed significant difference between 7
and 15 dot a (two-way ANOVA ##p < 0.01) and a significant 5-fold increase of
ORO staining in sildenafil-treated compared to vehicle-treated animals at 15 dot
(Bonferroni’s test, *p < 0.05). Values are means ± SEM (n = 4–6). Values are
means ± SEM (n = 4–6 animals); (f) Double staining for ORO (red) and the
microglia/macrophage classical activation marker CD68 (green; upper panels)
or the alternative activation marker YM-1 (green; lower panels) in longitudinal
SC sections showing low ORO staining (arrows) in CD68+ cells in vehicle- and
sildenafil-treated mice and strong ORO staining in YM-1+ cells that were only
present in sildenafil-treated mice (right lower panel). Scale bar = 20 µm; (g) 3D
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rendering  of  microgia/macrophages  positive  for  the  M2-phenotype  marker
YM-1 (green) containing ORO-stained vesicles (red arrows); (h) Phagocytosis
of Dil-labeled myelin analyzed by flow-cytometry in BMDM treated for 24 h
with  8Br-cGMP  (500  µM)  or  sildenafil  (30  µM  and  100  µM)  alone  or  in
combination  with  IL-4  (20  ng/ml).  Values  are  means  ±  SEM  of  three
independent  experiments.  Two-way  ANOVA revealed  statistically  significant
differences between treatments ( p < 0.001). Bonferroni’s post-hoc analysis
indicated  significant  differences  of  cGMP-increasing  treatments  respect  to
control or IL-4-treated cells (*p < 0.05, **p < 0.01, ***p < 0.001); (i) Double
immunostaining for  YM-1 and Dil-labelled myelin showing colocalization in
IL-4 and sildenafil-treated BMDM
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Discussion
Our previous studies in the MOG-induced EAE model showed that daily
administration of the cGMP PDE5-I sildenafil at peak disease markedly
ameliorates clinical symptoms by preventing axonal loss and promoting
remyelination (Pifarre et al. 2011). We additionally showed that
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administration of sildenafil from disease onset prevents disease progression,
preserves axons and myelin, protects OLs at different stages of differentiation
and increases the proportion of axons presenting thinner than normal but
compact myelin sheaths suggestive of remyelination (Pifarre et al. 2014;
Pifarre et al. 2011). Beneficial effects of sildenafil have been also described in
cuprizone-induced demyelination in C57BL/6 mice. In this model, animals
receiving sildenafil simultaneously with cuprizone for a 30 day period, did
not present the motor limitations shown by the cuprizone control group and
their cerebellar myelin and axon ultrastructure was preserved (Nunes et al.
2012). More recently the same group showed that the treatment increases
MBP levels and improves myelin structure (Nunes et al. 2016). However, in
contrast to our results in the EAE mice these effects were not observed in the
cuprizone model when sildenafil treatment was initiated 15 days after
inducing neurodegeneration. Demyelination in the cuprizone model is caused
by depletion of mature OLs in the brain without involvement of the immune
system that occurs in the EAE model (Matsushima and Morell 2001). Thus a
possible explanation for the difference in therapeutic effect of sildenafil
administration in the two models could be that the protective and
remyelinating effects observed in EAE were secondary to sildenafil
immunoregulatory actions. In this context, we previously demonstrated that
therapeutic administration of sildenafil decreases T cell infiltration and
microglial/macrophage activation in the SC while increasing the presence of
Tregs (Pifarre et al. 2011). Moreover, analysis of splenocytes from animals
treated with sildenafil from disease onset that were re-exposed to MOG in
vitro showed down-regulation of Th1/Th2/Th17 responses while Tregs were
up-regulated. Sildenafil additionally prevented MOG-specific IgG2b
accumulation in serum indicating that it also decreases the B cell response
(Pifarre et al. 2014). Altogether, these results demonstrated that sildenafil
treatment regulates innate and adaptive immune responses. To investigate if
peripheral immunoregulatory effects were determinant in the remyelinating
effect of sildenafil in the present work we used cerebellar organotypic
cultures demyelinated with LPC, a preparation proven to be an excellent in
vitro model to study demyelination-remyelination processes without the
interference of the immune system (Birgbauer et al. 2004; Zhang et al. 2011).
As previously reported, confocal analysis of control cultured cerebellar slices
showed a significant colocalization of immunostaining for myelin (MBP+)
and axons (NF200) with a regular distribution of nodes of Ranvier
(Carsp Caspr+ pairs) and after LPC exposure, myelin debris and naked axons
with occasional signs of damage evidenced by the presence of axonal bulbs
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could be observed. Furthermore, Caspr clusters associated with axons were
drastically reduced indicating disruption of nodes of Ranvier and loss of
functionality in nerve impulse (Coman et al. 2006). However, when LPC-
demyelinated cultures were treated with sildenafil for 10 days starting 24 h
after LPC removal myelin sheaths reappeared and the remyelination index
was notably increased. This effect was accompanied by a significant increase
in myelin protein expression and recovery of Caspr distribution over axons.
These results indicate that sildenafil promotes potentially functional
remyelination through direct actions on CNS cells. The combination of
sildenafil with a direct activator of NO-GC (BAY41) or with the ionotropic
glutamate receptor agonist NMDA that stimulates NO production by the Ca -
dependent NOS-1 activity in cerebellar granule cells (Garthwaite 1991),
induced a similar remyelination as sildenafil alone suggesting the
participation of endogenously generated NO in the action of the PDE5-I. This
was confirmed by the observation that the remyelinating effect of sildenafil
was prevented by inhibitors of NO-GC (ODQ) and NOS (L-NNA) activities.
OLs, the cells responsible for myelin production, have been shown to generate
cGMP by activation of NO-GC in culture (Benjamins and Nedelkoska 2007;
Garthwaite et al. 2015) and in brain slices (Garthwaite et al. 2015; Tanaka et
al. 1997; Teunissen et al. 2000). The small amounts of NO produced under
physiological conditions by the constitutive Ca -dependent NOS-1 in
neurons and to a smaller extend in astrocytes (Murphy et al. 1993), have been
implicated in physiological processes such as synaptic plasticity, brain
development, visual and sensory processing and cerebral blood flow
(Contestabile et al. 2012). We hypothesised that in LPC-demyelinated
cerebellar slices an aditional source of NO could be NOS-2 induction in
reactive glial cells (Murphy 2000). Reactive gliosis is a characteristic feature
of neuroinflammation (Aloisi 2001; Dong and Benveniste 2001) and in
cerebellar organotypic cultures soon after LPC-induced demyelination
maximal reactivity of both microglia and astroglia has been observed
(Birgbauer et al. 2004; Miron et al. 2010). Using NOS-2 immunostaining, we
showed 24 h after LPC-induced demyelination a notable increase in NOS-2+
cells presenting a rounded morphology more typical of reactive microglia
than of reactive astrocytes that are highly ramified. An excess NO production
after NOS-2 induction has been traditionally associated to cell damage
(Brown and Neher 2010), however our results suggest that NO produced by
NOS-2 in demyelinated cerebellar slices may have a beneficial effect by
stimulating cGMP-dependent remyelination. In support of this assumption,
recent studies in the cuprizone-induced demyelination model have shown that
2+
2+
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NOS-2  mice suffer more severe inflammation and damaged myelin
structure than wild type mice (Raposo et al. 2013).
AQ1
Previous studies have demonstrated that the NO-cGMP pathway promotes
protection against OL apoptotic death in vitro (Benjamins and Nedelkoska
2007). In agreement with this, we previously demonstrated protection of
immature and mature OLs from apoptotic cell death in the SC of EAE mice
treated with sildenafil from disease onset (Pifarre et al. 2014). Here we have
additionally shown that treatment with sildenafil to EAE mice for 15 days
starting at peak disease increaseds immunostaining for the transcription factor
Nkx2.2, a marker of activated and proliferating OPCs (Fancy et al. 2004).
Furthermore, double immunostaining for the transcription factor Olig2,
expressed from early to advanced OL maturation stages (Fancy et al. 2004),
and for MBP, a mature OL marker, indicated that sildenafil promotes the final
OL differentiation stage (MBP+/Olig2- cells) both in SC of EAE mice and in
demyelinated cerebellar cultures. These results support the implication of OL
maturation in the remyelinating effect of the PDE5-I. Increased levels of the
mature OL marker GST-pi have been also observed in the cuprizone
demyelinating model after sildenafil treatment (Nunes et al. 2016). A role for
cGMP-mediated pathways in OL differentiation and maturation is also
supported by the increase in the number of nestin-neural stem cells
differentiating into OPCs and mature OLs (CNPAse + and CC1+) observed in
the corpus callosum and striatum of ischemic mice treated with sildenafil
(Zhang et al. 2012). Furthermore, recent studies in cultures of rat cortex OLs
have shown that increasing cGMP by exposure to NO in the presence of a
PDE-I promotes the morphological differentiation of these cells (Garthwaite
et al. 2015).
PKG is a major target of cGMP and the two isoforms of this enzyme, PKGI
and PKGII, are expressed in the CNS and mediate important regulatory
actions of cGMP in neurons, astrocytes and OLs (Feil et al. 2005). Our results
using the specific PKG inhibitor Rp-8pCPTcGMP indicate that this activity is
mediating sildenafil-induced remyelination in cerebellar demyelinated
cultures. Importantly, PKG is known to phosphorylate and activate ERK and
Akt (Das et al. 2008; Mejia-Garcia et al. 2013), two kinases involved in OL
protection and differentiation. Phosphorylation by Akt inactivates GSK3β, an
effect reported to promote survival, proliferation and maturation of OPCs and
remyelination in vivo (Azim and Butt 2011; Luo et al. 2014). Furthermore,
−/−
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Akt downstream effector mTOR appears to be critically important for OPC
differentiation and myelination both in vitro and in vivo (Gaesser and Fyffe-
Maricich 2016; Narayanan et al. 2009; Tyler et al. 2009). Apart from direct
effects on OL maturation by potentiating cGMP-mediated pathways, sildenafil
could also exert indirect effects by inducing release of neurotrophic factors in
neighbor cells. We have previously shown that sildenafil treatment from
disease onset potentiates expression of BDNF in immune and CNS cells in the
SC of EAE mice (Pifarre et al. 2014). BDNF is involved in neuronal survival,
differentiation, plasticity and axonal growth, and also supports OL
proliferation and axon remyelination (De Santi et al. 2009; Weishaupt et al.
2012). Furthermore, studies in mice with selective removal of BDNF
expression in astroglial or immune cells have demonstrated the importance of
BDNF expression in these cells as a protective mechanism in EAE (Lee et al.
2012; Linker et al. 2010). CNTF is another promyelinating factor with a
recognized influence on OL maturation (Stankoff et al. 2002). In vitro studies
have demonstrated that CNTF expression in astrocytes is up-regulated by the
NO-cGMP-PKG pathway and that astrocyte-derived CNTF enhances OL
protection, differentiation and myelin protein production (Modi et al. 2013;
Paintlia et al. 2013). In agreement with this, we have shown here that CNTF
immunoreactivity notably increases in cells with astrocyte morphology in the
SC of EAE animals treated with sildenafil. We have also observed that cGMP
increasing treatments induce CNTF mRNA expression, but not that of BDNF
(not shown) in LPC-demyelinated cerebellar cultures. Taken together these
results suggest that enhancement of CNTF production in astrocytes together
with BDNF production in infiltrating immune cells may contribute to
sildenafil-induced OL protection and maturation in EAE mice.
Recent studies have shown that after LPC-induced demyelination in mice
corpus callosum, a switch from a M1 to a M2 phenotype occurs in resident
microglia and peripherally-derived macrophages at the initiation of
remyelination (Miron et al. 2013). In the same work it was demonstrated that
OL differentiation was impaired in vivo following M2 cell depletion at the
lesion site and was enhanced in vitro by the addition of M2 cell conditioned
media, suggesting that polarization of microglia/macrophages to the M2
phenotype promotes remyelination. Our previous results showed that
treatment with sildenafil to EAE mice from disease onset increased the
expression of the alternative activation marker YM-1 in the SC (Pifarre et al.
2014). Here we have confirmed that cGMP stimuli alter the inflammatory
phenotype of BMDM. In these cells, sildenafil induced a morphological
e.Proofing http://eproofing.springer.com/journals/printpage.php?token=W0VTQU...
29 de 43 31/7/17 11:32
change from a rounded/amoeboid type to an elongated shape similar to that
induced by IL-4 and notably potentiated the increase in arginase activity
induced by the cytokine, suggesting that it had a pro-M2 phenotype effect. In
contrast, sildenafil did not significantly inhibit the accumulation of nitrites in
the media of LPS + INFγ-treated cells. In agreement with these results, a
cGMP analogue potentiated the IL-4-induced increase in the number of cells
expressing the M2 marker CD206 but had no effect on the number of cells
expressing the M1 marker NOS-2 in response to LPS + INFγ. However, it did
have an inhibitory effect on the release of the pro-inflammatory cytokines
IL-1 β and TNF-α. Decreased pro-inflammatory cytokine release has been
previously demonstrated in different populations of rodent macrophages
including BMDM in response to the particulate GC agonist atrial natriuretic
peptide A (ANP) (Kiemer and Vollmar 2001). However, in contrast to our
results NOS-2 expression was also inhibited by ANP-stimulation of cGMP
formation. Increasing cGMP by inhibiting its degradation was also found to
decrease the release of TNF-α induced by LPS in isolated human monocytes
(von Bulow et al. 2005). Unexpectedly, we also observed that the cGMP
analogue alone induced a significant TNF-α production in unpolarized and
M2-polarized BMDM. Up-regulation of TNF-α synthesis by cGMP has been
reported in other macrophage populations (Arias-Diaz et al. 1995; Renz et al.
1988), but the mechanism and significance of this effect is unknown at
present. Taken together our results in BMDM indicate that an increase in
cGMP can induce or potentiate a M2 anti-inflammatory phenotype but not
properly induce a shift M1-M2.
An important function of microglia/macrophages in neurodegenerative
diseases is the clearance by phagocytosis of apoptotic cells and of myelin
debris produced as a consequence of the damage (Ransohoff and Perry 2009).
In demyelinating diseases, OL differentiation into mature myelinating cells is
not observed in the demyelinated areas (Wolswijk 2000) and in vitro and in
vivo studies have shown that the presence of myelin impairs OLs maturation
(Robinson and Miller 1999). Our studies using ORO staining in the SC of
EAE mice demonstrate that sildenafil treatment induces a notable increase of
lipid vesicles in infiltrates compared to vehicle-treated controls indicating that
the drug promotes myelin phagocytosis. Furthermore, confocal analysis of
double staining for ORO and M1 or M2 markers indicated that while in
vehicle-treated animal’s cells engulfing ORO-stained vesicles were largely
M1 microglia/macrophages, in sildenafil-treated animals a much larger
proportion of lipid-rich vesicles were inside M2 cells. In agreement with this,
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treatments with sildenafil or a cGMP analogue promoted myelin phagocytosis
by BMDM. Our results in EAE animals and in BMDM are in line with recent
reports indicating that M2 cells have higher myelin phagocytic activity than
M1 cells (Durafourt et al. 2012) and that M2 cell polarization contributes to
efficient remyelination (Miron et al. 2013).
Effects of sildenafil on the blood-brain barrier (BBB) and on cerebral blood
flow could also contribute to its neuroprotective and regenerative actions in
EAE animals. Using an in vitro BBB model (Wong et al. 2004) showed that
increasing cGMP enhanced trans endothelial electrical resistance and reversed
the increased permeability of the monolayers induced by IL-1β, IFN-γ, and
LPS. Moreover, it has been reported that PDE5 inhibitors enhance endothelial
cell migration, growth, and organization into capillary-like structures in vitro,
as well as angiogenesis in vivo (Pifarre et al. 2010; Pyriochou et al. 2007;
Zhang et al. 2003). Increased vascularization together with vasodilation has
been correlated with sildenafil-induced reduction in neurological damage and
enhanced functional recovery in a stroke model (Ding et al. 2008). MS
patients show evidence of reduced cerebral blood flow in grey and white
matter and seem to have an increased risk for ischemic stroke (D'Haeseleer et
al. 2011). Interestingly, an fMRI study in a small cohort of secondary
progressive MS patients that had been prescribed sildenafil as a treatment for
erectile dysfunction exhibited increases in grey and white matter perfusion
(Manson et al. 2005).
In summary, results shown here indicate that treatment with the PDE5-I
inhibitor sildenafil promotes remyelination in CNS demyelinated tissue by
potentiating the cGMP-PKG pathway in different cell types. We previously
demonstrated that sildenafil treatment to EAE animals at disease onset
protects immature and mature myelinating OLs, we now additionally show
that the sildeanfil promotes OL maturation in the SC of EAE animals and in
LPC-demyelinated organotypic cultures. This effect can be exerted by directly
increasing cGMP in OLs (Garthwaite et al. 2015) or indirectly by the
induction and release of the oligodendrocyte differentiation factor CNTF in
neighboring astrocytes shown here. Sildenafil induction of phenotypic
changes in microglia/ macrophages can also be an important mechanism
contributing to cell protection and regeneration of demyelinated tissue. We
previously showed that sildenafil treatment increased the expression of the
microglial/macrophage M2 phenotype YM1 in spinal cord of EAE animals
(Pifarre et al. 2014). We have now confirmed in cultured macrophages that
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increasing cGMP promotes a M2 anti-inflammatory phenotype and we further
show in vitro and in SC of EAE animals that sildenafil treatment increases the
myelin phagocytic activity of these cells, an effect recognized to contribute to
OL precursor differentiation (Kotter et al., 2016) and efficient remyelination
(Miron et al. 2013). Results presented here together with our previous
demonstration in the EAE model that sildenafil, at a dose within the range of
those demonstrated to be safe in clinical assays for chronic administration in
humans (Potter et al. 2012; Sommer et al. 2007), down-regulates the adaptive
immune responses and induces BDNF expression in immune and neural cells
in parallel to axon and OL protection, and also that human T regulatory cell
activity is potentiated by sildenafil in vitro (Pifarre et al. 2014), further
support the therapeutic potential of PDE5-Is for treatment of MS.
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